Fusion Pharmaceuticals' Series A - II Round

Fusion Pharmaceuticals raised a round of funding on September 25, 2017.

Fusion Pharmaceuticals is a biopharmaceutical company developing targeted alpha-particle radiotherapeutics for treating cancer.…

Articles about Fusion Pharmaceuticals' Series A - II Round: